Skip to main content
. 2010 Feb 17;2010(2):CD003499. doi: 10.1002/14651858.CD003499.pub3

Comparison 5. Oxcarbazepine versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Aggression (self‐reported): OAS‐M‐revised, number of responders as > 49% reduction in Global Overt Aggression score, at 10 wks 1 45 Odds Ratio (M‐H, Fixed, 95% CI) 4.88 [1.36, 17.47]
2 Non‐compliance: leaving the study early, any reason 1 48 Odds Ratio (M‐H, Fixed, 95% CI) 0.51 [0.16, 1.61]
3 Non‐compliance: leaving the study early, due to adverse events 1 48 Odds Ratio (M‐H, Fixed, 95% CI) 2.33 [0.51, 10.69]
4 Non‐compliance: leaving the study early, due to ineffectiveness 1 48 Odds Ratio (M‐H, Fixed, 95% CI) 0.24 [0.06, 0.90]